Piper Sandler Lifts Hinge Health Target to $71 After Q3 Beat and Raised Guidance

Hinge Health, Inc. (NYSE:HNGE) is one of the best digital health stocks to buy now.

On November 5, 2025, Piper Sandler nudged its Hinge Health, Inc. (NYSE:HNGE) target to $71 (Overweight) after a Q3 that ran hotter than the models. Revenue landed at $154.2 million, up 53% year over year and roughly $12 million above consensus (FactSet/Street was about $142–$142.5 million). Piper said the beat was powered by yield improvements, and that upside flowed through at a 93.4% incremental margin to adjusted operating income; Hinge itself reported non-GAAP operating income of $30.4 million and non-GAAP gross margin of 83%.

Guidance backed the momentum: Q4 revenue was guided to $155–$157 million, comfortably ahead of the Street’s ~$145.5 million, and the company raised its 2025 revenue outlook to $572–$574 million versus consensus near $550.6 million. Piper’s read was that the current yield trajectory still looks conservative relative to those updated targets, with efficiency gains in care delivery doing the heavy lifting.

Hinge Health, Inc. (NYSE:HNGE)  is a musculoskeletal digital clinic that offers personalized physical therapy and pain management programs through a combination of wearable sensors, app-based coaching, and licensed clinical care. Its platform serves employers, health plans, and individuals across the United States.

While we acknowledge the potential of HNGE as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None.